Results 161 to 170 of about 5,803 (182)
Some of the next articles are maybe not open access.

Ledipasvir/sofosbuvir

Reactions Weekly, 2016
  +9 more sources

Ledipasvir/sofosbuvir

Reactions Weekly, 2022
  +4 more sources

Ledipasvir/sofosbuvir

Reactions Weekly, 2019
  +5 more sources

Ledipasvir/sofosbuvir

Reactions Weekly, 2023
openaire   +2 more sources

Ledipasvir/sofosbuvir

Reactions Weekly, 2021
openaire   +2 more sources

Sofosbuvir/ledipasvir in combination or nitazoxanide alone are safe and efficient treatments for COVID-19 infection: A randomized controlled trial for repurposing antivirals

Arab Journal of Gastroenterology, 2022
Mohamed El-Kassas, Sherief Abd-Elsalam
exaly  

Spectroflurimetric estimation of the new antiviral agent ledipasvir in presence of sofosbuvir

Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2018
Ahmed El-Olemy   +2 more
exaly  

Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C

Journal of Hepatology, 2018
Peter Buggisch   +2 more
exaly  

Pharmacokinetics and pharmacodynamics of sofosbuvir and ledipasvir for the treatment of hepatitis C

Expert Opinion on Drug Metabolism and Toxicology, 2017
Antonio Rivero, Antonio Rivero-Juárez
exaly  

Micellar‐based spectrofluorimetric method for the selective determination of ledipasvir in the presence of sofosbuvir: application to dosage forms and human plasma

Luminescence, 2020
Ramadan Ali   +2 more
exaly  
sofosbuvir
hepatitis c
daclatasvir
medicine
treatment
medicine general
direct-acting antivirals
simeprevir
chronic hepatitis c
previous   15  16  17  18  19  

Home - About - Disclaimer - Privacy